  > find route for omeprazole
  ✓  resolve_to_smiles  4.8s
  ✓  identify_retrons  0.0s     arget · search_by_product_similarity…
  ✓  inspect_target  0.2s
  ✓  search_by_product_similarity  4.9s
  ⠧ Reasoning…e  0.0s      plan_route…
  ✓  find_retro_precedent  0.2s
  ✓  search_literature  0.0s     tes · smiles_to_info…
  ✓  search_notes  0.1s
  ✓  smiles_to_info  6.0s
  ✓  apply_hte_templates  0.1s

◆ Hypothesis  [50%]
  I'll help you find a synthetic route for omeprazole
  (native tool calling)

⎿ Tools
  resolve_to_smiles  →  identify_retrons  →  inspect_target  →  search_by_product_similarity  →  plan_route  →  find_retro_precedent  →  search_literature  →  search_notes  →  smiles_to_info  →  apply_hte_templates

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

## Retrosynthetic Route for Omeprazole

  **Target:** Omeprazole (Prilosec)
  **SMILES:** `COc1ccc2nc(S(=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1`
  **IUPAC:** 6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole
  **CAS:** 73590-58-6
  **MW:** 345.4 g/mol | **Complexity:** High (BertzCT = 920.8)

  ---

### Target Analysis

  | Property | Value |
  |----------|-------|
  | Rings | 3 (all aromatic: benzimidazole + pyridine) |
  | Stereocenter | 1 at sulfoxide sulfur (chiral) |
  | Rotatable bonds | 5 |
  | Key functional groups | Sulfoxide, benzimidazole, aryl methyl ethers, pyridine |

  **Strategic insight:** Omeprazole is a **sulfoxide-linked biheteroaryl** structure. The canonical disconnection is **not** a C–C coupling (as the automated retrons suggest), but rather **S-alkylation followed by sulfoxidation** — the industrial route.

  ---

### Recommended Retrosynthetic Route (Industrial)

#### Key Disconnection: S–CH₂ Bond

  ```
  Omeprazole (sulfoxide)
      ↓ [oxidation: m-CPBA, H₂O₂, or NaOCl]
  Pyrimethamine + Thiol Intermediate
  ```

  The strategic bond is the **S–CH₂ linkage** connecting the benzimidazole to the pyridine fragment.

  ---

### Stepwise Retrosynthesis

  **Step 1: Sulfoxide Reduction (Retrosynthetic)**

  **Reaction:** `Sulfide → Sulfoxide oxidation`

  **Forward direction:** Oxidation of the corresponding sulfide to sulfoxide

  **Precursor:**

- `COc1ccc2nc(SCc3ncc(C)c(OC)c3C)[nH]c2c1` (omeprazole sulfide)

  **Conditions:** m-CPBA (1.1 equiv), DCM, −10 to 0°C; or H₂O₂/AcOH; or NaOCl. The oxidation must be controlled to stop at sulfoxide (overoxidation to sulfone is a known impurity).

  ---

  **Step 2: S–Alkylation Disconnection**

  **Reaction SMILES:** `COc1ccc2nc(SH)[nH]c2c1.Cc1ncc(CBr)c(OC)c1C >> COc1ccc2nc(SCc3ncc(C)c(OC)c3C)[nH]c2c1`

  **Precursors:**

  1. **2-Mercaptobenzimidazole derivative:** `COc1ccc2nc(SH)[nH]c2c1` (5-methoxy-2-mercaptobenzimidazole)
  2. **Pyridine-methyl halide:** `Cc1ncc(CBr)c(OC)c1C` (2-chloromethyl-4-methoxy-3,5-dimethylpyridine, also known as the "pyridine fragment")

  **Conditions:** Base (K₂CO₃ or NaH), DMF or acetone, 50–80°C. SN2 alkylation of thiolate with the chloromethyl pyridine.

  ---

  **Step 3: Benzimidazole Fragment Synthesis**

  The 5-methoxy-2-mercaptobenzimidazole is prepared from:

- **4-Methoxy-o-phenylenediamine** + **Carbon disulfide** (CS₂) or **potassium ethyl xanthate** followed by cyclization

  **Classic route:**
  `4-MeO-C₆H₃(NH₂)₂ + CS₂ + base → 2-mercaptobenzimidazole`

  ---

  **Step 4: Pyridine Fragment Synthesis**

  The 2-chloromethyl-4-methoxy-3,5-dimethylpyridine is prepared via:

- **Pyridine synthesis** (e.g., Hantzsch-type condensation or related methods)
- **Chlorination of 2-hydroxymethyl pyridine** with SOCl₂ or PCl₅

  Alternative: Direct methylation/halogenation of pyridine-2-methanol derivatives.

  ---

### Complete Forward Synthesis (Industrial Route)

  ```
  Step 1: Benzimidazole fragment
  4-Methoxy-o-phenylenediamine + CS₂
  → 5-Methoxy-2-mercaptobenzimidazole
  (conditions: KOH, EtOH, reflux)

  Step 2: Pyridine fragment
  2,4-Dimethoxypyridine or related precursor
  → 2-Chloromethyl-4-methoxy-3,5-dimethylpyridine
  (conditions: methylation, chlorination sequence)

  Step 3: S-Alkylation
  5-Methoxy-2-mercaptobenzimidazole +
  2-Chloromethyl-4-methoxy-3,5-dimethylpyridine
  → Omeprazole sulfide
  (conditions: K₂CO₃, DMF, 60-80°C)

  Step 4: Sulfoxidation
  Omeprazole sulfide + oxidant
  → Omeprazole
  (conditions: m-CPBA, DCM, −10°C; or NaOCl, pH-controlled)
  ```

  ---

### Alternative Routes from Automated Analysis

  The HTE-backed templates also identified these viable disconnections:

  | Route | Reaction | Precursor 1 | Precursor 2 | Difficulty |
  |-------|----------|-------------|-------------|------------|
  | A | Negishi C–C | Aryl bromide (pyridine) | Alkylzinc (benzimidazole-CH₂-SO-) | 0.40 |
  | B | SNAr C–O | Aryl fluoride (benzimidazole) | Methanol | 0.25 |
  | C | Pd-catalyzed C–O | Aryl bromide (benzimidazole) | Methanol | 0.40 |

  **Assessment:** These are synthetically valid but **not the preferred industrial route**. The S-alkylation/oxidation approach is shorter, uses inexpensive reagents, and avoids transition metal catalysis and sensitive organometallics.

  ---

### Stereochemistry Note

  Omeprazole is a **racemic sulfoxide**. The chiral sulfoxide is generated in the final oxidation step. Enantioselective sulfoxidation can be achieved with:

- **Chiral Ti-salen catalysts** + H₂O₂
- **Biocatalytic oxidation** (cyclooxygenase or related enzymes)

  The (S)-enantiomer is esomeprazole (Nexium), a blockbuster drug.

  ---

### Summary

  | Parameter | Value |
  |-----------|-------|
  | **Total steps** | 4 (from commercial building blocks) |
  | **Key reactions** | Benzimidazole cyclization, S-alkylation (SN2), sulfoxidation |
  | **Challenges** | Stereocontrol at sulfur (if enantiopure); avoiding overoxidation to sulfone |
  | **Literature precedent** | AstraZeneca process chemistry; multiple patent routes (US 4,255,431; US 4,508,905) |

  **Confidence:** HIGH — This is a well-established industrial synthesis with extensive patent literature. The S-alkylation/oxidation route is the canonical approach used commercially.

  **Next steps:** For detailed experimental procedures with exact quantities and workup, I recommend consulting the original patents or Organic Process Research & Development publications on omeprazole manufacturing.
